Portfolio company
Pillar Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops next-generation sequencing kits and software for clinical laboratories, pharmaceutical companies and clinicians to perform oncology testing and precision medicine.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Personal Genome Diagnostics (PGDx)
This company develops genomic profiling kits for cancer diagnosis and treatment selection for use by laboratories and pharmaceutical companies worldwide.
NGeneBio
This company develops next-generation sequencing based cancer diagnostic panels and clinical analysis software for hospitals, research institutions and pharmaceutical companies.
Swift Biosciences
This company develops next-generation sequencing library preparation kits for researchers in academic, translational and clinical laboratories.
GenomOncology
This company develops software platforms to analyse and interpret genomic data for molecular pathology labs, clinical oncologists and research institutions.
4BASES
This company develops diagnostic genetic testing kits and sequencing reagents for healthcare professionals and clinical laboratories to support precision medicine and disease prevention.
Predicta Biosciences
This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.
Strata Oncology
This company provides genomic profiling tests and data software to help healthcare systems and pharmaceutical firms match cancer patients with precision therapies.
Genomill Health
Genomill Health develops targeted sequencing technology for liquid biopsies to assist clinical laboratories and pharmaceutical companies with precision cancer diagnostics.
